Treatment of Long Femoropopliteal Occlusive Lesions With Self-expanding Interwoven Nitinol Stent: 24 Month Outcomes of the STELLA-SUPERA-SIBERIA Register Trial.
Alexander A GostevOlesia S OsipovaAlexey V ChebanShoraan B SaayaArtem A RubtsunPavel V IgnatenkoAndrey A KarpenkoYann GouëfficPublished in: Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2023)
Our study indicated, that using self-expanding interwoven nitinol stent for TASC C/D femoropopliteal lesions revascularization appears to be a safe and efficient implant given the complexity of the treated lesions. Although bypass grafting is recommended for prolonged femoropopliteal lesions, open surgery is more traumatic and is associated with greater risks than endovascular procedures. Our findings suggest that the use of interwoven nitinol stents can overcome the disadvantages of traditional stents in such cases, which may help to improve patients' outcomes and reduce the risk of adverse events.
Keyphrases
- minimally invasive
- end stage renal disease
- newly diagnosed
- spinal cord injury
- clinical trial
- chronic kidney disease
- randomized controlled trial
- prognostic factors
- type diabetes
- study protocol
- acute coronary syndrome
- peritoneal dialysis
- percutaneous coronary intervention
- patient reported
- coronary artery bypass grafting
- atrial fibrillation
- surgical site infection
- human health
- insulin resistance
- endovascular treatment
- replacement therapy
- weight loss